Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
42
days
Precision medicine in genitourinary malignancies: integrating molecular profiling into clinical practice
Authors
Katrina Collins; Liang ChengShow moreShow less
Affiliations
1. Medical University of South Carolina; 2. Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University HealthShow moreShow less
52
days
Uveal melanoma: innovations in therapy, prognosis, and imaging
Authors
Nikhith Rao; Shrihari Nagarajan; Lauren A. DalvinShow moreShow less
Affiliations
1. Mayo ClinicShow moreShow less
83
days
Myelodysplastic syndromes/neoplasms presenting with isolated thrombocytopenia: a poorly understood pathophysiology, difficult to diagnose, and challenging to treat entity
Authors
Shehab F. Mohamed; Mohammed Abdulgayoom; Abdulrahman F. Al-Mashdali; Rowan Mesilhy; Jan Philipp Bewersdorf; Amer M. ZeidanShow moreShow less
Affiliations
1. Hamad Medical Corporation (HMC); 2. Yale School of MedicineShow moreShow less
101
days
Apalutamide in prostate cancer: clinical evidence, disease modification hypothesis, and emerging treatment de‑intensification strategies
Authors
Martina Catalano; Giandomenico RovielloShow moreShow less
Affiliations
1. Hospital of Bolzano; 2. University of FlorenceShow moreShow less
84
days
How zongertinib was developed for HER2-mutant non-small cell lung cancer: a plain language summary
Authors
John V Heymach; Birgit WildingShow moreShow less
Affiliations
1. aDepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2. bDepartment of Medicinal Chemistry, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, AustriaShow moreShow less
124
days
Targeting KIT and PDGFRA mutations in advanced GIST: current and future clinical implications
Authors
Alice Costa; Annalisa Astolfi; Livia Gozzellino; Maria Concetta Nigro; Maria Abbondanza Pantaleo; Margherita NanniniShow moreShow less
Affiliations
1. IRCCS Azienda Ospedaliero-Universitaria di Bologna; 2. University of BolognaShow moreShow less
FAQ
How long does Expert Review of Anticancer Therapy take to review a manuscript?
As of 2026-11-19, CrushSCI has 20 complete review records for Expert Review of Anticancer Therapy. The fastest paper went from submission to acceptance in 42 days (Precision medicine in genitourinary malignancies: integrating molecular profiling into clinical practice, received 2026-10-07, accepted 2026-11-18); the slowest took 272 days. The average is 99.3 days and the median is 87.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
